Martin Borch Jensen | BiotechTV

top of page

Search

Gordian Biotechnology is introducing a method of screening hundreds of gene therapies simultaneously in an individual animal model - its co-founders explain

Gordian Biotechnology is introducing a method of screening hundreds of gene therapies simultaneously in an individual animal model - its co-founders explain

Gordian Biotechnology is introducing a method of screening hundreds of gene therapies simultaneously in an individual animal model - its co-founders explain

Francisco LePort and Martin Borch Jensen describe the science behind the mosiac screening process.

Apr 25, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page